In patients with myelodysplastic syndromes with del(5q), factors other than age and sex contribute to the prognostic advantage, which diminishes over time

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|170|5|687-693

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.170, Iss.5, 2015-09, pp. : 687-693

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q)

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 2015-10 ,pp. : 210-214

John Wiley & Sons Inc

Access to resources Recommend Favorite

CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q)

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 2, 2015-10 ,pp. : 210-214

John Wiley & Sons Inc

Access to resources Recommend Favorite

Validation of the Revised International Prognostic Scoring System for Patients with Myelodysplastic Syndromes

By  

Acta Haematologica, Vol. 131, Iss. 4, 2013-12 ,pp. : 231-238

Karger

Access to resources Recommend Favorite

Autoimmune Disorders in Two Patients with Myelodysplastic Syndrome and 5q Deletion

By  

Acta Haematologica, Vol. 113, Iss. 2, 2005-03 ,pp. : 146-149

Karger

Access to resources Recommend Favorite

Comparing the prognostic value of risk stratifying models for patients with lower‐risk myelodysplastic syndromes: Is one model better?

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : 1036-1040

John Wiley & Sons Inc

Access to resources Recommend Favorite